PYRIMIDINHYDRAZIDFORBINDELSER I DERS EGENSKAB AF PGDS-INHIBITORER

This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma an...

Full description

Saved in:
Bibliographic Details
Main Authors STOKLOSA, GRZEGORZ, T, JIANG, JOHN, Z, FENNIE, MICHAEL, W, MU, LAN, PEDGRIFT, BRIAN, THURAIRATNAM, SUKANTHINI, VANDEUSEN, CHRISTOPHER, L, PRIBISH, JAMES, R, RAUCKMAN, BARBARA, SABOL, JEFFREY, S, ALDOUS, SUZANNE, C, JOHN, STANLY
Format Patent
LanguageDanish
Published 15.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
AbstractList This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).
Author FENNIE, MICHAEL, W
JOHN, STANLY
SABOL, JEFFREY, S
STOKLOSA, GRZEGORZ, T
PRIBISH, JAMES, R
PEDGRIFT, BRIAN
THURAIRATNAM, SUKANTHINI
MU, LAN
ALDOUS, SUZANNE, C
JIANG, JOHN, Z
RAUCKMAN, BARBARA
VANDEUSEN, CHRISTOPHER, L
Author_xml – fullname: STOKLOSA, GRZEGORZ, T
– fullname: JIANG, JOHN, Z
– fullname: FENNIE, MICHAEL, W
– fullname: MU, LAN
– fullname: PEDGRIFT, BRIAN
– fullname: THURAIRATNAM, SUKANTHINI
– fullname: VANDEUSEN, CHRISTOPHER, L
– fullname: PRIBISH, JAMES, R
– fullname: RAUCKMAN, BARBARA
– fullname: SABOL, JEFFREY, S
– fullname: ALDOUS, SUZANNE, C
– fullname: JOHN, STANLY
BookMark eNrjYmDJy89L5WRwDIgM8vT1dPH084h0CXKM8nRx8w9y8vRzcfUJdg1S8FRwcQ0KVnB1d_UL9nZ0UnB0UwhwdwnWBSr3dPIM8Q9yDeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEu3kaGJkamhmYhIcbGxKgBAB5nLUs
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID DK2142516TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_DK2142516TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 14:56:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Danish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_DK2142516TT33
Notes Application Number: DK20080744426T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130415&DB=EPODOC&CC=DK&NR=2142516T3
ParticipantIDs epo_espacenet_DK2142516TT3
PublicationCentury 2000
PublicationDate 20130415
PublicationDateYYYYMMDD 2013-04-15
PublicationDate_xml – month: 04
  year: 2013
  text: 20130415
  day: 15
PublicationDecade 2010
PublicationYear 2013
RelatedCompanies SANOFI
RelatedCompanies_xml – name: SANOFI
Score 2.8860128
Snippet This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PYRIMIDINHYDRAZIDFORBINDELSER I DERS EGENSKAB AF PGDS-INHIBITORER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130415&DB=EPODOC&locale=&CC=DK&NR=2142516T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7UatSbVk2tj2BiuG3kUagXYoCFgqRAKJrWSwMLTXqhjcX49x02Rb3obbO7mcxu8s1rd2YA7jWmsybzjOhqrhO0_wuSyfmSFLrKlFJhoxF_aJ-EuvcyfJ5psw6s2lwYXif0kxdHREQxxHvN5fXmJ4hF-d_K7UO-wqn1k5saVNx5xyiQUSGJ1DKcOKKRLdq2QQMxTIymspgm66m6B_toRY8aMDivVpOUsvmtUdwTOIiRWFWfQqfIenBkt43XenA42b1343AHve0ZmPE8QUFD_dCb08R88yn6b5Yf0iZelAi-0CQLCM7YCaeBaQmmK8RjOiW43bf8NEqc5BzuXCe1PYK8LL7PvaBBy3WqqhfQrdZV2QchV5YKKwtJLh7LYZajh8MUNcvkAuFaSky6hMHfdAb_LV7BscK7PQyJrF1Dt37_KG9Q59b5Lb-tLwQ2gIs
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL_MaZxvOjU6vzAxvDUOGMwXYoDCqGyMMDTbXhYoLNnLtjiM_75Hs6kv-ta0zeXa5Hdf7d0BPOjc4FXmGTG0zCBo_-ckVbI5yQ2Nq4XKu13x0D4IDf-18zLWxzVY7HJhRJ3QT1EcERHFEe-lkNfrnyAWFX8rN4_ZAqdWz15iUnnrHaNARoUkU9t0oyEdOrLjmDSQw9isKovpipFoe7CPFna3AoP7ZldJKevfGsU7hoMIiS3LE6jlaRMazq7xWhMOB9v3bhxuobc5BSuaxChoKAv9CY2tKaPov9kspFW8KJaYVCULSG7PDUeBZUuWJ0U9OiK4ndksGcZufAb3nps4PkFeZt_nntFgx3WiaedQX66WxQVImTpXeZG3lfyp6KQZejhc1dJUyRGuRZu3L6H1N53Wf4t30PCTQX_WZ2FwBUeq6PzQIYp-DfXy_aO4Qf1bZrfi5r4AN0CDfg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRIMIDINHYDRAZIDFORBINDELSER+I+DERS+EGENSKAB+AF+PGDS-INHIBITORER&rft.inventor=STOKLOSA%2C+GRZEGORZ%2C+T&rft.inventor=JIANG%2C+JOHN%2C+Z&rft.inventor=FENNIE%2C+MICHAEL%2C+W&rft.inventor=MU%2C+LAN&rft.inventor=PEDGRIFT%2C+BRIAN&rft.inventor=THURAIRATNAM%2C+SUKANTHINI&rft.inventor=VANDEUSEN%2C+CHRISTOPHER%2C+L&rft.inventor=PRIBISH%2C+JAMES%2C+R&rft.inventor=RAUCKMAN%2C+BARBARA&rft.inventor=SABOL%2C+JEFFREY%2C+S&rft.inventor=ALDOUS%2C+SUZANNE%2C+C&rft.inventor=JOHN%2C+STANLY&rft.date=2013-04-15&rft.externalDBID=T3&rft.externalDocID=DK2142516TT3